CRTC1 and diffuse large B-cell lymphoma: Due to the low induction of apoptosis after PQR620 as a single agent, we assessed the combination of the dual TORC1/2 inhibitor and the BCL2 inhibitor venetoclax in four DLBCL cell lines.